dc.contributor.author |
Monostory Katalin |
|
dc.contributor.author |
Pascussi JM |
|
dc.contributor.author |
Szabó Pál Tamás |
|
dc.contributor.author |
Temesvári Manna |
|
dc.contributor.author |
Kőhalmy Krisztina |
|
dc.contributor.author |
Acimovic J |
|
dc.contributor.author |
Kocjan D |
|
dc.contributor.author |
Kuzman D |
|
dc.contributor.author |
Wilzewski B |
|
dc.contributor.author |
Bernhardt R |
|
dc.contributor.author |
Kóbori László |
|
dc.contributor.author |
Rozman D |
|
dc.date.accessioned |
2015-01-05T09:37:48Z |
|
dc.date.available |
2015-01-05T09:37:48Z |
|
dc.date.issued |
2009 |
|
dc.identifier |
59649121381 |
|
dc.identifier.citation |
pagination=375-385;
journalVolume=37;
journalIssueNumber=2;
journalTitle=DRUG METABOLISM AND DISPOSITION; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/884 |
|
dc.identifier.uri |
doi:10.1124/dmd.108.023887 |
|
dc.relation.ispartof |
urn:issn:0090-9556 |
|
dc.title |
Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent |
|
dc.type |
Journal Article |
|
dc.date.updated |
2014-12-22T11:00:41Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
113074 |
|
dc.identifier.wos |
000262623000020 |
|
dc.identifier.pubmed |
18971317 |
|
dc.contributor.department |
MTA TTK/MTA KK/Biomolekuláris Kémiai Intézet (KK 2011-ig!) |
|
dc.contributor.department |
MTA TTK/MFI/MFI jogelőd 2012 előtt |
|
dc.contributor.department |
SE/ÁOK/K/Transzplantációs és Sebészeti Klinika |
|
dc.contributor.institution |
MTA Természettudományi Kutatóközpont |
|
dc.contributor.institution |
Semmelweis Egyetem |
|
dc.mtmt.swordnote |
[004/2009]
MTA KK |
|